• Profile
Close

A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias

CNS Drugs Jun 23, 2018

Penninkilampi R, et al. - Researchers examined if the risk of dementia is linked to benzodiazepine use in elderly patients, after controlling for protopathic bias. Observational studies were identified with no language limits including more than 50 cases, satisfactory evaluation of benzodiazepine exposure, and dependable diagnosis of dementia from the MEDLINE, PubMed, EMBASE, CINAHL, LILACS and CENTRAL electronic databases through to June 5, 2018. Due to protopathic bias, the relationship between benzodiazepine use and dementia incidence was not purely an artifact. Findings suggested that reduction of inappropriate benzodiazepine prescription would probably weaken dementia risk.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay